ArticleCureus2024
Efficacy and Clinical Utility of Sodium Fluoride Tubes Versus Serum Tubes for Blood Glucose Estimation.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPrecise and accurate measurement of blood glucose is the key factor in both the diagnosis and effective management of diabetes mellitus. The blood glucose levels are influenced by the time interval between sample collection and measurement as glycolysis continues to take place in the blood cells. Laboratories make efforts to minimize this change. This study aimed to analyze the differences in blood glucose levels between routine serum tubes and sodium fluoride (NaF) tubes over time intervals.
methodsThe study included 50 participants from whom blood was collected in both serum and NaF tubes. The blood glucose values between the two were compared using the Wilcoxon signed-rank sum test at time intervals of one, two, and six hours and the level of agreement in measuring the blood glucose levels by the Bland-Altman plot.
resultsThere were statistically significant variations in median glucose values between serum and NaF tubes across all the time intervals. The study found that 62%, 70%, and 100% of patients showed decreased glucose values in serum tubes at the end of one, two, and six hours, respectively, compared to NaF tubes. The Bland-Altman plot analysis indicated high agreement at all three time points. However, the difference in blood glucose levels varied from 5.6 mg/dL to 18.74 mg/dL from one to six hours, which was clinically very significant. All the values are clinically very significant as it would lead to underdiagnosing of diabetes mellitus and gestational diabetes mellitus.
conclusionThe study demonstrated that NaF tubes may offer better preservation of glucose levels, especially over extended periods implying that NaF tubes will help prevent under-diagnosis of diabetes mellitus.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.